Logo Image
|Articles|January 16, 2015

PenThu® Officially Registered and Available in the Market

Europital announces the official launching and certification attainment of its latest product.

Europital announces the official launching and certification attainment of its latest product. From January 2015 “Penthu®: The Future of Medical Management in Clinical Trials” will be available in the market.

Penthu® is an innovative and intuitive platform that drives performance, knowledge and efficiencies in clinical trials. This electronic tool allows project team to provide timely medical guidance and effficiently manage medical issues across multiple projects with minimal effort from the user’s side, thus reducing time, energy and resources while maximizing quality, knowledge and transparency.

This communication and knowledge trasnfer platform has been developed by clinical research professional and founded in three-core principles:

  • Creating, managing and deploying all medical guidance resources to the entire study team.

  • Providing team members global access to a searchable medical guidance repository with a means to request new guidance to the Responsible Team Members.

  • Overseeing, tracking and measuring the progress of the project and the performance of the team.

Thanks to an interactive environment that provides the kind of transparency needed to share and access information, the team’s performance is increased, creating real partnerships between project members.

Recently, PenThu® became an officially registered trademark in Europe. The European OHIM issued last November 2014 the Certificate of Registration for PenThu® as a Registered Trademark in the 28 member states of the European Union.

For more information about PenThu, visit www.pethu.com

Related to this article

View more
© C Davids/peopleimages.com - © C Davids/peopleimages.com - stock.adobe.com
What "Patient Voice" Actually Requires: Beyond the Buzzword
The clinical research industry talks about patient-centeredness constantly but embeds it too late, too narrowly, and without clear ownership, and the cost shows up in enrollment failures, protocol deviations, and outcomes that don't reflect what patients actually care about.
Read more
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.
Read more